226 related articles for article (PubMed ID: 29221435)
1. Exploring digenic inheritance in arrhythmogenic cardiomyopathy.
König E; Volpato CB; Motta BM; Blankenburg H; Picard A; Pramstaller P; Casella M; Rauhe W; Pompilio G; Meraviglia V; Domingues FS; Sommariva E; Rossini A
BMC Med Genet; 2017 Dec; 18(1):145. PubMed ID: 29221435
[TBL] [Abstract][Full Text] [Related]
2. Absence of a primary role for TTN missense variants in arrhythmogenic cardiomyopathy: From a clinical and pathological perspective.
Chen K; Song J; Wang Z; Rao M; Chen L; Hu S
Clin Cardiol; 2018 May; 41(5):615-622. PubMed ID: 29750433
[TBL] [Abstract][Full Text] [Related]
3. Penetrance of mutations in plakophilin-2 among families with arrhythmogenic right ventricular dysplasia/cardiomyopathy.
Dalal D; James C; Devanagondi R; Tichnell C; Tucker A; Prakasa K; Spevak PJ; Bluemke DA; Abraham T; Russell SD; Calkins H; Judge DP
J Am Coll Cardiol; 2006 Oct; 48(7):1416-24. PubMed ID: 17010805
[TBL] [Abstract][Full Text] [Related]
4. Whole exome sequencing with genomic triangulation implicates CDH2-encoded N-cadherin as a novel pathogenic substrate for arrhythmogenic cardiomyopathy.
Turkowski KL; Tester DJ; Bos JM; Haugaa KH; Ackerman MJ
Congenit Heart Dis; 2017 Mar; 12(2):226-235. PubMed ID: 28326674
[TBL] [Abstract][Full Text] [Related]
5. Whole-Exome Sequencing Identifies Pathogenic Variants in TJP1 Gene Associated With Arrhythmogenic Cardiomyopathy.
De Bortoli M; Postma AV; Poloni G; Calore M; Minervini G; Mazzotti E; Rigato I; Ebert M; Lorenzon A; Vazza G; Cipriani A; Bariani R; Perazzolo Marra M; Husser D; Thiene G; Daliento L; Corrado D; Basso C; Tosatto SCE; Bauce B; van Tintelen JP; Rampazzo A
Circ Genom Precis Med; 2018 Oct; 11(10):e002123. PubMed ID: 30354300
[TBL] [Abstract][Full Text] [Related]
6. Compound and digenic heterozygosity contributes to arrhythmogenic right ventricular cardiomyopathy.
Xu T; Yang Z; Vatta M; Rampazzo A; Beffagna G; Pilichou K; Scherer SE; Saffitz J; Kravitz J; Zareba W; Danieli GA; Lorenzon A; Nava A; Bauce B; Thiene G; Basso C; Calkins H; Gear K; Marcus F; Towbin JA;
J Am Coll Cardiol; 2010 Feb; 55(6):587-97. PubMed ID: 20152563
[TBL] [Abstract][Full Text] [Related]
7. Generation of two edited iPSCs lines by CRISPR/Cas9 with point mutations in PKP2 gene for arrhythmogenic cardiomyopathy in vitro modeling.
Amin G; Castañeda SL; Zabalegui F; Belli C; Atorrasagasti C; Miriuka SG; Moro LN
Stem Cell Res; 2023 Sep; 71():103157. PubMed ID: 37393721
[TBL] [Abstract][Full Text] [Related]
8. Truncating plakophilin-2 mutations in arrhythmogenic cardiomyopathy are associated with protein haploinsufficiency in both myocardium and epidermis.
Rasmussen TB; Nissen PH; Palmfeldt J; Gehmlich K; Dalager S; Jensen UB; Kim WY; Heickendorff L; Mølgaard H; Jensen HK; Baandrup UT; Bross P; Mogensen J
Circ Cardiovasc Genet; 2014 Jun; 7(3):230-40. PubMed ID: 24704780
[TBL] [Abstract][Full Text] [Related]
9. Clinical profile in arrhythmogenic cardiomyopathy and a recessive plakophilin-2 gene mutation.
Ali M; Bhat IA; Hafeez I; Dar MI; Beig JR; Shah ZA; Iqbal K
Indian Heart J; 2018; 70(3):421-426. PubMed ID: 29961461
[TBL] [Abstract][Full Text] [Related]
10. Recessive variants in plakophilin-2 contributes to early-onset arrhythmogenic cardiomyopathy with severe heart failure.
Chen K; Rao M; Guo G; Duru F; Chen L; Chen X; Song J; Hu S
Europace; 2019 Jun; 21(6):970-977. PubMed ID: 30830208
[TBL] [Abstract][Full Text] [Related]
11. Progressive Reduction in Right Ventricular Contractile Function Attributable to Altered Actin Expression in an Aging Mouse Model of Arrhythmogenic Cardiomyopathy.
Camors EM; Roth AH; Alef JR; Sullivan RD; Johnson JN; Purevjav E; Towbin JA
Circulation; 2022 May; 145(21):1609-1624. PubMed ID: 35437032
[TBL] [Abstract][Full Text] [Related]
12. Contribution of exome sequencing for genetic diagnostic in arrhythmogenic right ventricular cardiomyopathy/dysplasia.
Fedida J; Fressart V; Charron P; Surget E; Hery T; Richard P; Donal E; Keren B; Duthoit G; Hidden-Lucet F; Villard E; Gandjbakhch E
PLoS One; 2017; 12(8):e0181840. PubMed ID: 28767663
[TBL] [Abstract][Full Text] [Related]
13. Novel homozygous stop-gain pathogenic variant of PPP1R13L gene leads to arrhythmogenic cardiomyopathy.
Kalayinia S; Mahdavi M; Houshmand G; Hesami M; Pourirahim M; Maleki M
BMC Cardiovasc Disord; 2022 Aug; 22(1):359. PubMed ID: 35933355
[TBL] [Abstract][Full Text] [Related]
14. Plakophilin-2 missense mutations in arrhythmogenic right ventricular cardiomyopathy.
Lahtinen AM; Lehtonen A; Kaartinen M; Toivonen L; Swan H; Widén E; Lehtonen E; Lehto VP; Kontula K
Int J Cardiol; 2008 May; 126(1):92-100. PubMed ID: 17521752
[TBL] [Abstract][Full Text] [Related]
15. The Novel Variant NP_00454563.2 (
Robles-Mezcua A; Ruíz-Salas A; Medina-Palomo C; Robles-Mezcua M; Díaz-Expósito A; Ortega-Jiménez MV; Gimeno-Blanes JR; Jiménez-Navarro MF; García-Pinilla JM
Genes (Basel); 2023 Jul; 14(7):. PubMed ID: 37510372
[TBL] [Abstract][Full Text] [Related]
16. High risk of heart failure associated with desmoglein-2 mutations compared to plakophilin-2 mutations in arrhythmogenic right ventricular cardiomyopathy/dysplasia.
Hermida A; Fressart V; Hidden-Lucet F; Donal E; Probst V; Deharo JC; Chevalier P; Klug D; Mansencal N; Delacretaz E; Cosnay P; Scanu P; Extramiana F; Keller DI; Rouanet S; Charron P; Gandjbakhch E
Eur J Heart Fail; 2019 Jun; 21(6):792-800. PubMed ID: 30790397
[TBL] [Abstract][Full Text] [Related]
17. Clinical Findings and Diagnostic Yield of Arrhythmogenic Cardiomyopathy Through Genomic Screening of Pathogenic or Likely Pathogenic Desmosome Gene Variants.
Carruth ED; Beer D; Alsaid A; Schwartz MLB; McMinn M; Kelly MA; Buchanan AH; Nevius CD; Calkins H; James CA; Murray B; Tichnell C; Matsumura ME; Kirchner HL; Fornwalt BK; Sturm AC; Haggerty CM
Circ Genom Precis Med; 2021 Apr; 14(2):e003302. PubMed ID: 33684294
[TBL] [Abstract][Full Text] [Related]
18. Molecular insights into arrhythmogenic right ventricular cardiomyopathy caused by plakophilin-2 missense mutations.
Kirchner F; Schuetz A; Boldt LH; Martens K; Dittmar G; Haverkamp W; Thierfelder L; Heinemann U; Gerull B
Circ Cardiovasc Genet; 2012 Aug; 5(4):400-11. PubMed ID: 22781308
[TBL] [Abstract][Full Text] [Related]
19. A targeted next-generation gene panel reveals a novel heterozygous nonsense variant in the TP63 gene in patients with arrhythmogenic cardiomyopathy.
Poloni G; Calore M; Rigato I; Marras E; Minervini G; Mazzotti E; Lorenzon A; Li Mura IEA; Telatin A; Zara I; Simionati B; Perazzolo Marra M; Ponti J; Occhi G; Vitiello L; Daliento L; Thiene G; Basso C; Corrado D; Tosatto S; Bauce B; Rampazzo A; De Bortoli M
Heart Rhythm; 2019 May; 16(5):773-780. PubMed ID: 30453078
[TBL] [Abstract][Full Text] [Related]
20. MYH10 activation rescues contractile defects in arrhythmogenic cardiomyopathy (ACM).
García-Quintáns N; Sacristán S; Márquez-López C; Sánchez-Ramos C; Martinez-de-Benito F; Siniscalco D; González-Guerra A; Camafeita E; Roche-Molina M; Lytvyn M; Morera D; Guillen MI; Sanguino MA; Sanz-Rosa D; Martín-Pérez D; Garcia R; Bernal JA
Nat Commun; 2023 Oct; 14(1):6461. PubMed ID: 37833253
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
